{
    "symbol": "ACCD",
    "quarter": 1,
    "year": 2022,
    "date": "2021-07-08 23:39:08",
    "content": " Your line is open. So you could think of the revenue impact from cross selling is fairly minor and that, that $300 million to $305 million topline revenue guidance we're giving for the year, really has a lot more to do with core organic growth from Accolade and then on its own 2nd.MD strong growth continuing there, and then PlushCare as well, both of which you will recall we signaled that those companies we expect to grow in the 35% to 40% rate on their own, so to speak, as we're bringing together that integration and coming to market with Accolade maintaining that growth rate on a core organic basis at 25% or so which pencils out to that guidance range. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open."
}